Skip to main content
Nature Communications logoLink to Nature Communications
. 2026 Aug 15;17:8414. doi: 10.1038/s41467-026-76758-z

Sub-millivolt voltage imaging reveals gap junction-mediated bioelectric contact inhibition

Philipp Rühl 1,✉, Rama A Hussein 1, Stefanie Reuter 2, Konrad S Frahnert 1, Anagha G Nair 1, Ralf Mrowka 2,3, Roland Schönherr 1, Stefan H Heinemann 1
PMCID: PMC13477479  PMID: 42603816

Abstract

Sub-millivolt membrane potential (Vm) dynamics in multicellular non-excitable networks have remained largely inaccessible due to insufficiently sensitive imaging tools. Here, we introduce rEstus2s, a next-generation genetically encoded voltage indicator that overcomes this barrier by enabling high-resolution Vm imaging. Using rEstus2s, we uncover bioelectric contact inhibition (BCI), a biophysical principle in which gap junction coupling passively stabilizes Vm by suppressing electrical volatility. We show that Vm variance scales inversely with network size (1/n), reflecting a transition from stochastic single-cell behavior to collective electrical stability. Ca²⁺-activated oncogenic ion channels, including ANO1 and KCa3.1, drive pronounced electrical volatility in isolated cells, but BCI effectively attenuates this volatility in electrically coupled networks. Disruption of gap junction coupling abolishes BCI and restores high electrical volatility. These findings establish a unifying framework for how multicellular systems maintain electrical homeostasis and reveal gap junction coupling as a key determinant of bioelectric stability in health and disease.

Subject terms: Fluorescent proteins, Ion transport, Multicellular systems


Few methods allow highly sensitive and non-invasive measurements of cellular membrane potentials. Here, authors introduce rEstus2s, a next-generation voltage indicator, and show that gap junctions stabilize networks by filtering electrical volatility from oncochannels.

Introduction

Bioelectric signaling outside the classical framework of excitable tissues is an emerging frontier in cell biology1–4. Ion transport proteins play essential roles in development, tissue homeostasis, and tumorigenesis, yet the mechanistic pathways by which they influence these phenotypes remain poorly understood5. In non-excitable cells, membrane potential (Vm) has traditionally been viewed as a static property reflecting the balance of ion conductance. However, recent evidence supports an active regulatory role for Vm in non-excitable cells, as membrane depolarization has been shown to directly activate the ERK signaling pathway, a central driver of proliferation and oncogenic transformation6,7. Vm also influences intracellular Ca2+ dynamics, either by regulating voltage-gated Ca2+ channels or by altering the electrochemical driving force for Ca2+ influx8,9. Specific ion channels, often referred to as oncochannels, are implicated in nearly all hallmarks of cancer, including sustained proliferation, resistance to apoptosis, and invasion5,10–12. Ca2+-activated ion channels such as ANO1 (ANO1, conducting Cl−) and KCa3.1 (KCNN4, conducting K⁺) are frequently overexpressed in malignancies, including head and neck squamous cell carcinoma (HNSCC) and pancreatic ductal adenocarcinoma (PDAC)13–20. Their upregulation stimulates ERK signaling14,21, correlates with tumor size, and is associated with poor clinical prognosis16,21,22.

In contrast, connexins, which form gap junctions between neighboring cells, are widely regarded as tumor suppressors23–25. Loss of gap junction coupling is a common early event in tumorigenesis, although connexins may reappear in advanced tumors where they promote migration and invasion24,26,27. Mouse models of PDAC expressing assembly-deficient connexin 43 (Cx43) exhibit accelerated tumor onset and enhanced ERK activation27,28. In non-excitable tissues, gap junctions are predominantly viewed as mediators of metabolite and second-messenger transfer or as structural scaffolds. Their electrical coupling function, central in excitable cells, is rarely addressed24. Levin and colleagues1 proposed that the loss of gap junctions in cancer marks a transition from altruistic, system-level behavior to an individualistic single-cell state, mediated largely through bioelectricity. In this framework, ion channels are thought to modulate long-term steady-state Vm, shaping cellular phenotypes through sustained depolarization or hyperpolarization3,29,30. However, recent studies, including our own, have revealed that many non-excitable cells also generate rapid, spontaneous Vm excursions on the second-to-millisecond timescale31–34. Thus, it is plausible that ion channels and connexins play roles in shaping the Vm dynamics in multicellular networks of non-excitable cells. In a previous study, we observed that endogenous Vm fluctuations in HEK293T cells diminish as cells reach confluency31. We propose that electrical coupling via connexins integrates individual cells into a functional electrical syncytium that acts as a biophysical filter, attenuating Vm dynamics35,36. Testing this hypothesis requires the ability to resolve subtle Vm fluctuations across the full physiological resting Vm range in intact, multicellular networks.

Conventional electrode-based electrophysiological techniques are sensitive but highly invasive and of low throughput. Genetically encoded voltage indicators (GEVIs) offer a non-invasive alternative, converting electrical signals into optical readouts with high temporal resolution37–41. GEVI development has largely focused on maximizing speed to capture neuronal action potentials, exemplified by indicators such as ASAP5 and JEDI-1P39,42. For non-excitable cells, sensitivity rather than speed is the limiting factor31,32. We previously addressed this challenge by developing rEstus, a bright and sensitive GEVI capable of resolving endogenous Vm dynamics in non-excitable cells31,43. However, rEstus exhibits a steep response curve in the depolarized range (0 to −50 mV), resulting in signal saturation under hyperpolarized conditions.

Here, we present rEstus2s, a next-generation GEVI generated through rational engineering that provides a twofold increase in Vm sensitivity over its precursor, rEstus and enables detection of sub-millivolt Vm changes in the range of −100 to 0 mV. Using rEstus2s in combination with CRISPR-Cas9 connexin knockout models, we demonstrate that the ion channels ANO1 and KCa3.1 enhance spontaneous Vm fluctuations in non-excitable cells, whereas cell-cell contact leads to a robust, cluster-size-dependent suppression of Vm fluctuations. This suppression, which we term bioelectric contact inhibition (BCI), strictly depends on electrical coupling through connexins. Together, our results establish BCI as a fundamental biophysical constraint on multicellular networks, providing insight into Vm dynamics in health and disease.

Results

Development of rEstus2s for sub-mV imaging across the resting Vm range

To obtain a GEVI with enhanced Vm sensitivity, we introduced mutations into the previously developed ultrasensitive GEVI, rEstus31. rEstus comprises a voltage-sensing domain (VSD) fused to a circularly permuted EGFP (Fig. 1a). For clarity, all mutations in the cpEGFP part of rEstus are referenced according to the numbering in EGFP. The chromophore in rEstus is an EGFP-type TYG motif (Fig. 1b)44. Conformational changes in many cpEGFP-derived sensors are thought to affect the flexibility of the chromophore, thereby influencing the brightness of the sensor. Thus, we introduced the T65G mutation (T311G in rEstus), resulting in a GYG-type chromophore, which has been shown to enhance flexibility in the excited state in EGFP44. The properties of rEstus and rEstus-T65G were characterized by the expression of N-terminal mKate2 fusion constructs of both sensors in HEK293T cells and subsequent fluorescence recordings under whole-cell voltage clamp conditions (Fig. 1c–f). mKate2 served as a reference to correct for fluorescence variations arising from differences in expression levels, as previously described31,45,46. Strikingly, although the maximum brightness (Rmax) of rEstus-T65G was approximately one-third of that of rEstus, the overall Vm sensitivity of the fluorescence, characterized by the total fractional change in brightness (Rmax/Rmin), increased from 4.5- to 9.6-fold (Fig. 1d–f).

Fig. 1. rEstus2s, a genetically encoded voltage indicator with enhanced voltage sensitivity.

Fig. 1

a 3D model of rEstus2s; positions 138 and 141 are highlighted in red. b Chromophore (green shading) and surrounding residues of EGFP (PDB: 2Y0G)78. c Voltage pulse protocol. d Fluorescence images (Fgreen) of HEK293T cells expressing rEstus or rEstus-T311G (T65G in EGFP), voltage-clamped to −120 or 80 mV. Scale bar, 20 µm. The experiment was repeated at least five times, yielding similar results. e Superposition of representative traces of Fgreen divided by the fluorescence of mKate2 (Fred), which was fused to the N-terminus to account for variations in expression levels. Mutations are given with respect to EGFP. Results of the established GEVIs ASAP3 and JEDI-1P are shown for comparison. f Fgreen / Fred as a function of voltage (R-V) from the data shown in (e). Data are means ± SEM, with superimposed Boltzmann-type fits (Eq. 1). g R–V relationship of rEstus2s; the fit to rEstus-LGL data is depicted for reference. The gray area indicates the physiological resting Vm range. h Fold change in fluorescence across the physiological resting Vm range for the indicated GEVIs. For multiple comparisons against rEstus2s, a one-way ANOVA followed by Dunnett’s post-hoc test was used (P = 2*10−6). Statistical significance is indicated as follows: P < 0.05, **P < 0.01, *** P < 0.001; n.s., not significant (P ≥ 0.05). i Normalized fluorescence response of rEstus2s (without mKate2) to bipolar voltage steps with sub-mV amplitude from a holding Vm of −50 mV. Respective images were acquired at 20 Hz with 400/470 nm co-illumination. j Signal-to-noise ratio (from (i)), calculated by dividing the steady-state fluorescence amplitude by the noise (standard deviation) at the holding Vm as a function of the stimulating voltage step size. Traces were recorded from holding voltages of 0 mV, −50 mV, and −100 mV. Data are presented as mean ± SEM. n represents individual cells (n = 6 for JEDI-1P; n = 5 for all other constructs). Source data are provided as a Source Data file.

To restore sensor brightness, we examined mutations that were introduced in other fluorescent proteins in combination with T65G. For example, EYFP (enhanced yellow fluorescent protein, with a GYG chromophore) harbors the additional mutations V68L, S72A, and T203Y, which are all near the chromophore (Fig. 1b)47. rEstus already contains S72A (S318A in rEstus), which we have previously shown to increase brightness relative to its precursor, ASAP3, by enhancing pH stability31. Mutation V68L (V314L in rEstus) not only enhanced the brightness of rEstus-T65G but also retained its high Vm sensitivity (11.7 ± 0.5-fold, Fig. 1e, f). In contrast, the introduction of V68L into rEstus strongly reduced its maximal brightness and voltage sensitivity (Fig. 1e, f). T203Y facilitates π-stacking and shifts the excitation and emission spectrum in YFP-type proteins. In rEstus-T65G-V68L, the introduction of T203Y (T206Y in rEstus) severely reduced both brightness and voltage sensitivity (Supplementary Fig. 1). We further evaluated mutation F46L (F292L in rEstus), which was initially reported in the SEYFP-derived mVenus and enhances chromophore maturation at 37 °C47. In rEstus-T65G and rEstus-T65G-V68L, mutation F46L increased the brightness of the sensors, while the same mutation did not affect the brightness of rEstus. The triple mutant rEstus-F46L-T65G-V68L (rEstus-LGL) exhibited approximately twice the brightness of rEstus-T65G and approximately 65% of the brightness of rEstus.

While rEstus-LGL exhibited enhanced voltage sensitivity (Fig. 1e, f), the half-maximal activation voltage (Vhalf) was shifted to −25 ± 3 mV, compared to −41 ± 3 mV in rEstus. Therefore, this mutant is best suited for cells with relatively depolarized Vm. As we aimed for a sensor operating best at more negative Vm, we introduced a previously characterized double mutation (G138N, T141I) into rEstus-LGL31,48; both residues are located in the S3 helix of the VSD and face the outer vestibule (Fig. 1a). The resulting rEstus-LGL-G138N-T141I (rEstus-NILGL) had a left-shifted Vhalf of −58.3 ± 1.3 mV (Fig. 1g) and exhibited a relative brightness change between 0 to −100 mV of 4.60 ± 0.23-fold, which was greater than that of any of the other examined sensors (Fig. 1h). The voltage sensitivity (dF/F dV-1) of GEVIs is itself voltage dependent and can be described as the relative change in fluorescence (dF/F) in response to small voltage steps (dV). Because dF/F dV-1 was higher for rEstus-NILGL than for any of the other tested sensors within the physiological voltage range (Supplementary Fig. 2), we termed this new variant rEstus2s.

rEstus2s fluorescence responded to depolarizing steps in a biexponential time course. For a depolarizing step from −100 to 0 mV at 23 °C, the time constants were 4.3 ± 0.4 ms (54.1 ± 1.6%) and 20.9 ± 2.0 ms (Supplementary Fig. 3). To estimate the effective detection limit of rEstus2s with our setup, we recorded fluorescence in response to square voltage pulses with amplitudes reaching into the sub-mV range at an acquisition rate of 20 Hz. While rEstus2s retains the standard green emission profile, it notably lacks the secondary excitation shoulder at approximately 400 nm observed in rEstus (Supplementary Fig. 4). Nevertheless, co-illumination of cells with 400 nm light allowed us to accelerate the kinetics of rEstus2s (Supplementary Fig. 5)49. Since voltage sensitivity is itself voltage-dependent, we recorded fluorescence-voltage relationships around three physiologically relevant resting voltages: 0, −50, and −100 mV. At all holding voltages, voltage pulses in the sub-mV range were clearly detectable as fluorescence changes (Fig. 1i and Supplementary Fig. 6). At each holding voltage, a 500 ms square pulse with an amplitude of 400 µV gave signals with a signal-to-noise ratio greater than 3 (Fig. 1j). The highest SNR was reached at a holding Vm of −50 mV.

Ca2+-activated ion channels drive Vm volatility in non-excitable cells

Leveraging the enhanced voltage sensitivity of rEstus2s, we investigated how the Ca2+-activated oncochannels ANO1 (Cl-) and KCa3.1 (K+) influence the Vm dynamics of non-excitable HEK293T cells (Fig. 2a–d). Given their respective ion selectivity, ANO1 and KCa3.1 are expected to generate electrical currents determined by the Nernst potentials for Cl− and K+ within the HEK293T system. By co-encoding the ion channel genes and rEstus2s on a single plasmid, we ensured consistent expression of both sensor and channels. Stable expression and function of ANO1 (Fig. 2b), KCa3.1 (Fig. 2c), and rEstus2s (Fig. 2d) were subsequently validated using whole-cell patch clamp and fluorescence imaging.

Fig. 2. Ca2+-activated K⁺ and Cl⁻ channels enhance Vm volatility in HEK293T cells.

Fig. 2

a Fluorescence image of HEK293T cells stably expressing rEstus2s-T2A-KCa3.1. Scale bar, 20 µm. The experiment was repeated at least ten times, yielding similar results. b Whole-cell patch clamp validation of ANO1 expression. Left: Representative current traces elicited by voltage steps from −120 mV through 120 mV. Right: Mean ± SEM current density–voltage relationship for HEK293T cells (Ctrl, black) and ANO1-expressing cells (yellow), showing characteristic outward rectification for ANO1. c Mean ± SEM whole-cell current density traces elicited by 500 ms voltage ramps in cells expressing rEstus2s (Ctrl) or rEstus2s-T2A-KCa3.1, using the same solutions as in (b). d Mean ± SEM normalized F–V relationships of cells stably expressing rEstus2s (Ctrl) or the indicated co-expression constructs. e Fluorescence traces of cells stably expressing rEstus2s (Ctrl) or one of the co-expression constructs. f, g Minimum (f) and maximum (g) fluorescence excursions during recordings for 60 s (as in e). Box plots show the median (center line), 25th/75th percentiles (box limits), and 10th/90th percentiles (whiskers). For statistical testing, a two-sided Wilcoxon rank-sum test was performed. Statistical significance is indicated as follows: *P < 0.05, **P < 0.01, *** P < 0.001; n.s., not significant (P ≥ 0.05). P-values are provided in Supplementary Data 2. h Mean ± SEM fluorescence power spectra for cells expressing the indicated GEVIs. SEM is indicated by shading. i, j Peak-to-peak fluorescence excursions (i) and absolute mean Vm (j) of individual and confluent cells expressing rEstus (Ctrl) or co-expression constructs. k, l Minimum (k) and maximum (l) fluorescence excursions in cells expressing rEstus2s and either ANO1 or KCa3.1 with or without 10 µM of the specific ion channel inhibitors Ani9 (ANO1) or Senicapoc (KCa3.1). m, n Mean ± SEM change in Fgreen of rEstus (m) and rEstus2s (n) without (Ctrl) and with co-expression of the indicated channels, induced by the application of the Ca2+ ionophore ionomycin (200 nM). The number of analyzed cells (b–l) or dishes (m, n) is indicated in parentheses. Source data are provided as a Source Data file.

Individual HEK293T cells expressing only rEstus or rEstus2s exhibited spontaneous Vm fluctuations (Fig. 2e–g), as previously reported31. The relative fluorescence change (peak-to-peak) was ≈55% higher for rEstus2s compared to rEstus, which is in agreement with the calculated ≈60% increase in sensitivity (dF/F dV-1) at −50 mV (the average resting Vm of HEK293T cells) from electrophysiological experiments (Supplementary Fig. 2). The spectral density of fluorescence recordings from rEstus2s was 2.4-fold higher than that of rEstus (Fig. 2h), underscoring its higher sensitivity. Expression of ANO1 or KCa3.1 resulted in spontaneous depolarizing or hyperpolarizing events, respectively (Fig. 2e–g). The amplitudes of these events exceeded the endogenous excursions observed in HEK293T cells, and rEstus2s yielded higher relative fluorescence changes than rEstus. KCa3.1 events had an average amplitude of 22.8 ± 1.1% (rEstus2s), a frequency of 2.0 ± 0.23 min−1, and a duration of 1.14 ± 0.12 s. ANO1 events had an average amplitude of −25.1 ± 0.9% and occurred with a frequency of 1.58 ± 0.21 min−1 (Fig. 2g). These depolarizing events of 0.58 ± 0.05 s were approximately half as long as the hyperpolarizing events induced by KCa3.1. Importantly, these large Vm fluctuations were only detectable in isolated HEK293T cells and not in cells that were part of confluent cell layers (Fig. 2i).

Confluent and individual HEK293T cells exhibited similar resting Vm of about −50 mV (Fig. 2j). The expression of ANO1 depolarized the cells to about −30 mV, both in individual and confluent states. Remarkably, while individual cells overexpressing KCa3.1 displayed similar or slightly lower resting Vm (≈−40 mV) than control HEK293T cells, confluent KCa3.1-expressing cells were hyperpolarized to about −65 mV. Since both channel types affected the resting Vm, it is not necessarily clear that the spontaneous Vm excursions originate from the respective channel activity. However, acute application of the channel-specific inhibitors Ani9 (ANO1) and Senicapoc (KCa3.1) eliminated these events, thus indicating channel-dependent activity (Fig. 2k, l). The responsiveness of the channels to intracellular Ca2+ level changes and the consequence for the average Vm was examined by application of the Ca2+ ionophore ionomycin, which is expected to maximally activate ANO1 and KCa3.1 (Fig. 2m, n). Control HEK293T cells exhibited a transient hyperpolarization following ionomycin treatment. In KCa3.1-expressing cells, this response was markedly enhanced and sustained, whereas ANO1-expressing cells displayed pronounced depolarization. Ionomycin-induced fluorescence changes were larger in cells expressing rEstus2s than rEstus, reflecting the increased voltage sensitivity of rEstus2s.

These results indicate that the Vm fluctuations arise from spontaneous openings of ANO1 and KCa3.1 channels and suggest that, in cells expressing these oncochannels, the resting Vm is not clamped near the respective Cl− or K⁺ Nernst potentials.

Ca2+ remains local while Vm is correlated across gap junctions

ANO1 and KCa3.1 channels induce spontaneous changes in Vm in HEK293T cells (Fig. 2) and are activated by elevations in intracellular Ca2+. To investigate whether channel activity correlates with transient increases in intracellular Ca2+, we used the red fluorescent Ca2+ indicator K-GECO1 alongside rEstus2s and performed simultaneous live-cell imaging of Vm and Ca2+ (Fig. 3a).

Fig. 3. The fluctuations in Vm, but not in Ca2+, correlate with the size of electrically connected cell networks.

Fig. 3

a Fluorescence images of a pair of HEK293T cells stably expressing K-GECO1-T2A-rEstus2s. Scale bar, 20 µm. top, Fgreen; bottom, Fred. The experiment was repeated at least ten times, yielding similar results. b Representative fluorescence traces of rEstus2s (top) and K-GECO1 (bottom) from the cells in (a), indicating spontaneous changes Vm and intracellular free Ca2+, respectively. Traces were recorded with alternating excitation at 470 nm and 530 nm. c Linear correlation of the time traces for rEstus2s (top) and K-GECO1 (bottom) from the cell pair shown in a. Coefficients of determination (r²) for the linear correlations (bold lines) are indicated. d r²-values from linear correlations of rEstus2s and K-GECO1 fluorescence for 45 cell pairs. Black rhombs are means. e Peak-to-peak excursions of relative rEstus2s (top) and K-GECO1 (bottom) fluorescence in individual cells, cell pairs (as in (d)), and confluent cells. Box plots show the median (center line), 25th/75th percentiles (box limits), and 10th/90th percentiles (whiskers). For statistical testing, a two-sided Wilcoxon rank-sum test was performed. Statistical significance is indicated as follows: *P < 0.05, **P < 0.01, ***P < 0.001; n.s., not significant (P ≥ 0.05). P-values are provided in Supplementary Data 2. f, g Representative normalized fluorescence traces of rEstus2s (top) and K-GECO1 (bottom) in HEK293T cells stably expressing K-GECO1-T2A-rEstus2s-T2A-KCa3.1 (f) or K-GECO1-T2A-rEstus2s-T2A-ANO1 (g). h, i Peak-to-peak excursions of relative rEstus2s (h) and K-GECO1 (i) fluorescence in individual and confluent cells expressing K-GECO1-T2A-rEstus2s (Ctrl) or additionally one of the indicated ion channel types. The number of analyzed cells is indicated in parentheses. Source data are provided as a Source Data file.

In HEK293T cells stably expressing K-GECO1-T2A-rEstus2s, spontaneous fluctuations in both intracellular Ca2+ and Vm were observed (Fig. 3b). Measurement of spontaneous Vm fluctuations in neighboring cells can be used to estimate the electrical coupling between them because strongly correlated Vm indicates an electrical connection with low resistance. We thus quantified electrical cell connectivity by fluorescence fluctuation correlation analysis (FFCA)31 applied to pairs of neighboring cells (Fig. 3b, c). Cell pairs exhibited strong synchrony in Vm but weak synchrony in Ca2+ signals (Fig. 3d), indicating that Vm changes propagate efficiently between neighboring HEK293T cells, whereas Ca2+ changes remain locally confined. Consistent with this observation, the amplitudes of Vm fluctuations but not Ca2+ fluctuations were strongly attenuated in confluent cell layers (Fig. 3e). If suppression of Vm fluctuations in confluent cultures was primarily driven by physical cell-cell contact and activation of membrane surface receptor pathways, one might expect a pronounced reduction in volatility upon formation of the first stable cell-cell junction. However, Vm fluctuations in cell pairs more closely resembled those observed in isolated cells rather than those in confluent cultures, indicating that the physical cell-cell contact alone has only a marginal effect on Vm volatility and is unlikely to account for the pronounced suppression of Vm dynamics in confluent monolayers.

Vm excursions arising from Ca2+-activated ion channel activity were not always accompanied by changes in global intracellular Ca2+ levels (Fig. 3f, g). In addition, Vm fluctuations were strongly attenuated at high cell densities (Fig. 3h), whereas global Ca2+ levels were not significantly affected by confluency (Fig. 3i). Yet, intracellular Ca2+ was slightly more variable in cells expressing ANO1 or KCa3.1 compared to control HEK293T cells. To test whether the activity of ANO1 and KCa3.1 is, in fact, stimulated by intracellular Ca2+, cells were pretreated with the membrane-permeable Ca2+ chelator BAPTA-AM. BAPTA-AM markedly reduced depolarizing events associated with ANO1 and hyperpolarizing events associated with KCa3.1 (Supplementary Fig. 8). These findings indicate that spontaneous ANO1 and KCa3.1 activity is driven by local rather than global increases in intracellular Ca2+.

Gap junctions mediate bioelectric contact inhibition

Endogenous Vm changes in HEK293T cells are markedly attenuated with increasing cell density. This effect was evident regardless of the overexpression of ANO1 or KCa3.1. A plausible explanation is passive low-pass filtering arising from the electrical coupling, presumably through gap junctions formed by connexins.

HEK293T cells, which we have shown above to exhibit efficient electrical coupling (Fig. 3d), express two major connexins: Cx43 (GJA1) and Cx45 (GJC1)20. We thus generated a Cx43 knockout (Cx43 KO) and a Cx43/Cx45 double knockout (Cx43/45 KO) HEK293T cell line using CRISPR-Cas9 (Fig. 4a) and confirmed the absence of the respective proteins by Western blot (Supplementary Fig. 7). Upon stable expression of rEstus2s in both knockout cell lines, FFCA was applied to quantify electrical coupling between neighboring cells (Fig. 4b–d). Similar to control HEK293T, Cx43 KO cells exhibited strong electrical coupling, whereas the coupling of Cx43/45 KO cells was strongly reduced (Fig. 4d). Overexpression of Cx43 in Cx43/45 KO cells restored strong electrical coupling, indicating that both Cx43 and Cx45 are functionally active in HEK293T cells and together account for most of the electrical coupling.

Fig. 4. Connexin knockout abolishes cell density-dependent bioelectric filtering in HEK293T cells.

Fig. 4

a Western blots of HEK293T cells and of Cx43 and Cx43/Cx45 knockout cell lines generated with CRISPR-Cas9. Vinculin was used as a loading control. The knockout of Cx43 and Cx45 in HEK293T cells was confirmed in three independent Western blot experiments. b Representative normalized fluorescence traces of two visually connected Cx43/Cx45 KO cells stably expressing rEstus2s. c Linear correlation of the time traces from b with superimposed linear fit (bold line). d r²-values from linear correlations of rEstus2s for Cx43 KO, Cx43/Cx45 KO, and Cx43/Cx45 KO with stable overexpression of Cx43. Black rhombs are means. For statistical testing, a two-sided Wilcoxon rank-sum test was performed. Statistical significance is indicated as follows: *P < 0.05, **P < 0.01, ***P < 0.001; n.s., not significant (P ≥ 0.05). P-values are provided in Supplementary Data 2. e, f Superimposed normalized fluorescence traces of 50 Cx43 KO cells each with rEstus2s, or Cx43/Cx45 KO cells with rEstus2s either alone or with additional overexpression of Cx43, ANO1, or KCa3.1. Cells were either individual (e) or in a confluent layer (f). g Peak-to-peak excursions of relative rEstus2s fluorescence in individual and confluent cells. The number of analyzed cells is indicated in parentheses. Box plots show the median (center line), 25th/75th percentiles (box limits), and 10th/90th percentiles (whiskers). Source data are provided as a Source Data file.

Vm fluctuations in Cx43 KO cells were markedly diminished when cell cultures had reached confluency (Fig. 4e–g). In contrast, when both connexins were knocked out, the density-dependent reduction in Vm fluctuations was strongly reduced. Reintroduction of Cx43 into Cx43/45 KO cells fully restored the density-dependent attenuation of Vm fluctuations. Cx43/45 KO cells also expressing ANO1 or KCa3.1 exhibited strong spontaneous Vm fluctuations as in regular HEK293T cells (Figs. 2i and 3h), but there was no longer any density-dependent attenuation of these fluctuations (Fig. 4e-g and Supplementary Movie 1). These data demonstrate that the observed attenuation of Vm excursions by ANO1 and KCa3.1 (Fig. 3h) was also caused by gap junction coupling rather than surface receptor interaction.

Loss of gap junction coupling impairs bioelectric contact inhibition

Loss of gap junction coupling is an established phenomenon in early tumorigenesis, whereas the re-expression of connexins is often observed in later metastatic stages24. Based on experiments with the Cx43/45 KO HEK293T cells (Fig. 4), we hypothesized that cell types lacking electrical coupling also lack density-dependent attenuation of electrical activity, a phenomenon we term bioelectric contact inhibition (BCI). We therefore examined a panel of cancerous and non-cancerous cell lines. We introduced rEstus2s into MCF-7 (breast cancer), Panc-1 (pancreatic ductal adenocarcinoma), A375 (melanoma), and non-cancerous HaCaT keratinocytes and HEK293T cells.

We characterized the expression of relevant ion channels and connexins using qPCR (Fig. 5a). mRNA coding for KCa3.1 was highest in A375 cells and negligible in HEK293T cells. ANO1 was strongly expressed in HaCaT cells. Panc-1 cells predominantly expressed Cx45, whereas HaCaT cells primarily expressed Cx31 (GJB3). Transcript levels for all three tested connexins were low in MCF-7 cells, aligning with the weak electrical coupling among MCF-7 cells, as we have reported previously31. The expression profiles are consistent with data from the Human Protein Atlas20.

Fig. 5. Cell types with reduced gap junction coupling lack cell density-dependent bioelectric filtering.

Fig. 5

a Relative mRNA expression of the indicated ion channel and connexin genes in HEK293T, HaCaT, MCF-7, Panc-1, and A375 cells. Expression levels were determined by qRT-PCR and normalized to β-actin. Data are means ± SEM. qPCRs were performed from three separate cDNA preparations. b, c Superimposed normalized fluorescence traces (50 cells each) of individual (b) and confluent (c) cells stably expressing rEstus2s. d Peak-to-peak excursions of relative rEstus2s fluorescence in individual cells, cell couples, and confluent monolayers. The number of analyzed cells is indicated in parentheses. Box plots show the median (center line), 25th/75th percentiles (box limits), and 10th/90th percentiles (whiskers). For statistical testing, a two-sided Wilcoxon rank-sum test was performed. Statistical significance is indicated as follows: *P < 0.05, **P < 0.01, *** P < 0.001; n.s., not significant (P ≥ 0.05). P-values are provided in Supplementary Data 2. e Quantification of electrical coupling strength using Fluorescence Fluctuation Correlation Analysis on cell pairs. The coefficient of determination (r2) serves as a measure of synchrony. Black rhombs indicate the means. The number of analyzed cells is indicated in parentheses. Source data are provided as a Source Data file.

Individual cells of all cell lines displayed spontaneous Vm fluctuations (Fig. 5b–d). While HEK293T cells predominantly showed spontaneous depolarizations, Panc-1, MCF-7, and A375 cells exhibited a complex mix of depolarizing and hyperpolarizing events. This heterogeneity suggests that, beyond ANO1 and KCa3.1, the electrical phenotype likely involves a diverse repertoire of other ion channels.

In confluent cell layers, all cell lines, with the exception of MCF-7, showed a significant reduction in Vm dynamics compared to individual cells or cell pairs (Fig. 5c, d), where the degree of reduction correlated with electrical coupling strength. FFCA (Fig. 5e) confirmed strong coupling in A375, HaCaT, and Panc-1 cells, while MCF-7 cells exhibited a substantially lower coupling strength. MCF-7 cells remained electrically active even at high density, with the majority of the monolayer functioning as uncoupled units. A375 cells, which had high Vm volatility in isolation, demonstrated a marked reduction in activity upon reaching confluency, indicative of strong BCI. It is worth noting that the electrical coupling in the other cancer lines was not always absolute. In Panc-1 monolayers, we observed subpopulations: some cells were fully decoupled, while others formed electrically coupled subsystems that generated slow oscillations independent of the surrounding monolayer (Supplementary Movie 2). This phenotype was notably more complex than that of HEK293T or HaCaT cells, where electrical activity was almost completely abolished at confluency. These data confirm that BCI is a general phenomenon of non-excitable cells that strictly depends on the electrical coupling strength within multicellular networks.

Bioelectric contact inhibition depends on the network size

The transition from individual cells to an electrically coupled functional electrical syncytium can be described by an equivalent circuit model (Fig. 6a)50. In this model, the plasma membrane acts as a capacitor (Cm) that resists Vm changes induced by current flow through stereotypic depolarizing (Rd) and hyperpolarizing (Rh) ion channels. Vm is determined by the open probability of these channels and the respective reversal potentials (Erev). When individual cells are connected through gap junction-mediated contacts, they establish low-resistance bridges (Rgj) between the individual cellular circuits. For the specific case where Rd ≈ Rh ≫ Rgj, the system behaves as a single large unit, where the total capacitance and conductance represent the sum of the individual cell components. Under this condition, the Vm of a single cell within the network becomes equivalent to the average Vm of the entire system. Conversely, the loss of connexins causes each cell to behave as an isolated electrical circuit, even at high cell density (Fig. 6b).

Fig. 6. Electrically coupled cell networks attenuate Vm dynamics in individual cells depending on the network size.

Fig. 6

a, b Schematic representation of bioelectric contact inhibition (a) and its loss (b). In multicellular networks, gap junctions (connexins) create strong electrical coupling, integrating individual cells into a functional syncytium. Loss of connexins, an early hallmark of tumorigenesis, results in weak or loss of electrical coupling. The electrical properties are depicted by the equivalent electrical circuit models: Rd and Rh are membrane resistances arising from stereotypical depolarizing and hyperpolarizing ion channels, respectively; Cm is the membrane capacitance; and Rgj is the gap junction resistance. Images were created using Inkscape. c Top: Representative fluorescence images of HEK293T cells expressing rEstus2s in clusters of varying sizes (individual, 2-cell, and 8-cell clusters). Scale bar, 40 µm. Bottom: Superimposed normalized fluorescence traces of 10 individual cells or 10 clusters of the corresponding size. d Peak-to-peak excursions of relative fluorescence as a function of cluster size (n). Box plots show the median (center line), 25th/75th percentiles (box limits), and 10th/90th percentiles (whiskers). The number of analyzed clusters is indicated in parentheses. e, f Average relative frequency distribution of fluorescence fluctuations for individual cells (e) and 8-cell clusters (f). Blue lines represent Gaussian fits. The variance (σ2) for each group is indicated, showing a reduction in volatility as cluster size increases. g Mean ± SEM variance of the normalized fluorescence as a function of cluster size. The solid line is the result of a 1/n fit (Eq. (4)). Source data are provided as a Source Data file.

Non-excitable cells are often characterized by low ion channel expression. When the open probability of these channels is low, they operate stochastically and act as independent noise sources that randomly inject current, causing spontaneous Vm fluctuations51. In this state, Vm of an individual cell is highly sensitive to perturbations from even minor current injections. However, as cells electrically connect, both the total number of channels and the membrane capacitance scale linearly with the number of cells (n), thereby stabilizing the system. If the average resting Vm is maintained by only a few active channels, Vm volatility is expected to follow the law of large numbers. Assuming every cell is electrically similar, the variance in Vm (σ2) should be inversely proportional to the number of cells (n); hence, σn2 ∝ 1/n.

To validate this model, we analyzed spontaneous Vm fluctuations in rEstus2s expressing HEK293T clusters of varying sizes (Fig. 6c). We found that the average peak-to-peak amplitude in Fgreen of these fluctuations systematically decreased with every additional cell added to the cluster (Fig. 6d). The Vm distributions around the mean were well-described by Gaussian functions (Fig. 6e), and the variance of an 8-cell cluster (Fig. 6f) was markedly reduced compared to that of individual cells. Notably, the reduction in Vm variance as a function of cluster size followed the predicted 1/n relationship (Fig. 6g). This confirms that Vm is maintained by stochastic channel fluctuations and shifts from stochastic to deterministic behavior depending on the network size. These findings establish that BCI is a fundamental physical property of electrically coupled networks, distinct from mechanical or chemical signaling mechanisms.

Discussion

One central achievement of this study is the development of rEstus2s. Current high-performing GEVIs are predominantly developed by directed evolution, which often requires hundreds to thousands of mutants to be tested on large-scale screening platforms37–41. Here, we pursued a rational engineering strategy that combines knowledge from decades of fluorescent protein optimization with our systematic analysis of how mutations in the VSD shape voltage-dependent optical responses of ASAP-type GEVIs31. While brighter than ASAP3, rEstus2s is slightly dimmer than rEstus and JEDI-1P. However, this reduction in brightness is outweighed by the substantial gain in sensitivity and dynamic range. To our knowledge, rEstus2s is more sensitive than any currently available GEVI across the entire physiological resting Vm range (0 to −100 mV). rEstus2s avoids saturation even at the edges of the physiological resting Vm range, allowing for the confident resolution of Vm changes below 1 mV. This feature is vital because the exact resting voltage of non-excitable and tumor cells is often unknown a priori. While literature frequently proposes that tumor cells are in general depolarized (0 to −50 mV)5,52, using quantitative Vm imaging, we previously demonstrated that the average Vm of HEK293T, MCF-7, and A375 cells actually resides in the −40 mV to −60 mV range31,45,48.

A limitation of rEstus2s is that it exhibits reduced excitation at 400 nm relative to rEstus and therefore cannot be calibrated by dual-excitation ratiometry. Consequently, although rEstus is less sensitive than rEstus2s, it remains the preferred choice for absolute Vm calibration. This limitation of rEstus2s is offset by its ability to support 400/470 nm co-illumination. This illumination scheme accelerates response kinetics without compromising sensitivity, likely by promoting voltage-dependent cis-trans chromophore isomerization through excitation of the protonated chromophore state49.

An alternative to GEVI-based approaches for bioelectric voltage imaging is the use of synthetic dye-based systems. In particular, PeT (photoinduced electron transfer)-based dyes have recently emerged as powerful tools in bioelectric research, as they can be calibrated for absolute Vm measurements using fluorescence lifetime imaging microscopy (FLIM) under appropriate conditions53–58. While these dyes generally exhibit lower voltage sensitivity (e.g., dsVF2.2(OMe). Cl shows a 1.63-fold intensity change over 100 mV)59 than the most recent GEVIs, such as rEstus2s (4.6-fold change over 100 mV), they provide a valuable, non-genetic alternative for tissue-level Vm imaging, particularly in contexts where genetic targeting is not feasible. Ratiometric and FLIM-based approaches are superior in situations where motion artifacts, dye distribution variability, or differences in GEVI expression levels need to be accounted for.

The development of rEstus2s was motivated by the need for tools capable of resolving how cancer-associated alterations, particularly the loss of connexin and the upregulation of oncochannels, reshape the electrical dynamics of non-excitable cells. While ion channels such as ANO1 and KCa3.1 have been associated with enhanced ERK signaling and altered proliferative or migratory behavior, these relationships are typically inferred from long-term phenotypic assays13–20. Here, we focus on the fast Vm dynamics generated by ion channel activity and demonstrate that these dynamics are fundamentally constrained by gap junction-mediated electrical coupling. Our results establish a unifying biophysical framework (BCI) describing how Vm fluctuations driven by ion channels are passively attenuated in electrically coupled multicellular networks, independent of potential downstream signaling pathways.

One of the prevailing models in cancer bioelectricity posits that a depolarized steady-state Vm is a key driver of tumorigenesis30,60,61. We observed that while overexpression of the oncochannels KCa3.1 and ANO1 shifted average Vm in opposite directions, Vm remained far from the reversal potentials for K+ or Cl–, respectively. This indicates that Vm is not dominated by any single ion species but instead reflects a balance among various conductances. The observation that the Vm variance scales with cluster size according to a 1/n relationship suggests that resting Vm is maintained by a small number of stochastically opening channels, rendering isolated cells or small clusters electrically volatile. Analogous to neuronal principles, where low channel density shifts a system from deterministic to stochastic behavior62,63, non-excitable cells exhibit substantial Vm fluctuations at the single-cell level. Electrical coupling through gap junctions suppresses this volatility, acting as a biophysical noise filter36,64. This noise filter is lost if gap junctions are downregulated during early tumorigenesis23,24. Computational models by Cervera et al50. demonstrate that multicellular networks can lock cells into synchronized, bistable resting Vm states. However, a critical distinction resides in the time domain: while these models primarily describe steady-state shifts occurring over hours, our data reveal that the electrical coupling through gap junctions suppresses Vm changes on the millisecond-to-second timescale.

Notably, despite robust electrical coupling through Cx43 and Cx45, intracellular Ca2+ dynamics remained unsynchronized even between neighboring HEK293T cells and were insensitive to network size. This suggests a functional separation of fast electrical coupling and slower metabolic or second-messenger coupling. Although connexins can indirectly support Ca2+ wave propagation through diffusion of signaling molecules such as IP₃23, the extent to which they permit direct Ca2+ flux remains unclear65. A functional separation between Ca2+ and Vm signaling has also been reported in neural crest explants57. The discrepancy between the observed functional electrical syncytium and the absence of coordinated Ca2+ dynamics remains an open question that warrants further investigation. A plausible explanation is that these processes are governed by fundamentally different biophysical constraints. Electrical coupling is mediated by ionic currents that rapidly equilibrate Vm across the network’s shared capacitance nearly instantaneously. In contrast, Ca2+ flux through gap junctions is limited by diffusion through narrow pores and is further constrained by strong intracellular buffering. Consequently, the level of junctional conductance required for effective electrical coupling is likely substantially lower than that required to achieve intercellular equilibration of Ca2+. In non-excitable contexts, gap junctions therefore appear to function primarily as low-resistance electrical conduits rather than as mediators of fast biochemical signaling. However, the functional role of electrical coupling and signaling in non-excitable cells remains incompletely understood and requires further investigation in physiologically relevant models, such as organoids derived from induced pluripotent stem cells66.

Unlike contact inhibition of proliferation or locomotion, which describe biological outcomes, BCI refers to a biophysical constraint on Vm imposed by electrical coupling, which may act upstream of these processes10,67–69. Mechanistically, while KCa3.1 may enhance the driving force for Ca2+ entry and ANO1 may depolarize the membrane and, e.g., directly activate ERK, the outcome is dictated by the functional electrical syncytium. As long as a cell is embedded in a large coupled network, it is electrically clamped; it cannot significantly alter its Vm unless (1) its membrane conductance exceeds the junctional conductance, (2) it uncouples from the network, or (3) the network changes its Vm coherently. Thus, under healthy conditions, connexins act as a biophysical brake, forcing individual cells to conform to the resting Vm of the tissue50. A similar community effect was previously described in theoretical models by Cervera et al.70.

A fundamental open question is whether Vm is instructive and, if so, whether the information is predominantly encoded as sustained steady-state changes or as transient fluctuations. It is well established that signaling outcomes can be encoded in the temporal dynamics of pathways such as ERK71. For example, transient ERK activation promotes proliferation, whereas sustained ERK activation drives differentiation72. Furthermore, stochastic ERK activity pulses regulate proliferation rates in a cell density-dependent manner73. Thus, if ERK signaling is modulated by Vm, as suggested by previous studies6,7, its dynamics may likewise be shaped by the collective electrical properties of the multicellular network.

The scaling of Vm fluctuations with cluster size suggests a mechanism by which individual cells could infer network size1,74. In this framework, localized current injection, for example, through the opening of KCa3.1 or ANO1 channels in a single cell, could act as a rapid electrophysiological ping, with the resulting Vm amplitude providing immediate feedback about the size of the surrounding cellular network75. In a growing tissue, this feedback could instruct proliferation until the network reaches a terminal size, at which point Vm signals are attenuated below a threshold required to sustain growth. It remains unresolved if endogenous Vm volatility itself serves as a signaling cue by transiently crossing critical voltage thresholds, or whether electrical stability primarily prevents individual cells from reaching such thresholds. These possibilities are not mutually exclusive and may differ among processes such as migration, proliferation, and differentiation. Because Vm is an emergent, system-level property rather than a purely cell-autonomous variable, it may also enable collective decision-making, permitting state transitions only when a sufficient fraction of the network changes coherently. Addressing these questions will require high-resolution, spatiotemporally resolved measurements linking Vm dynamics to downstream signaling events and lies beyond the scope of the present study. By providing both an ultrasensitive GEVI and a coherent biophysical framework, this study lays the groundwork for decoding the bioelectrical principles underlying tissue homeostasis and disease.

Methods

Molecular biology

For sensor development, an N-terminal fusion protein of the red fluorescent protein mKate2 and rEstus was used46. Point mutations were introduced into mKate2-rEstus using megaprimer mutagenesis. The positions of mutations within the cpEGFP component of rEstus are indicated relative to the EGFP sequence. All constructs were cloned into a pCDNA3.1-puro vector31, using EcoRI and NotI restriction sites. All sequences were validated by Sanger sequencing (Eurofins).

For stable coexpression of ANO1, KCa3.1, or Cx43, fusion proteins of rEstus/rEstus2s derivatives with the self-cleaving T2A peptide were generated. The promoter of pCDNA3.1-puro was replaced with an EF1α promoter. For stable expression with the Ca2+ indicator K-GECO176, a vector containing one or two T2A peptides was generated in the following configurations: K-GECO1-T2A-rEstus2s, K-GECO1-T2A-rEstus2s-T2A-ANO1, or K-GECO1-T2A-rEstus2s-T2A-KCa3.1. For lentiviral production rEstus2s was cloned into pCDH-EF1α-Puro-CMV. All constructs were validated by sequencing. For detailed sequence information, see the attached files (Supplementary Data 1).

Cell culture

HEK293T cells were obtained from the Center for Applied Microbiology and Research (CAMR; Porton Down, Salisbury, UK). MCF-7 (#86012803) cells were obtained from the European Collection of Authenticated Cell Cultures (ECACC; Porton Down, Salisbury, UK). A375 (#CRL-1619) and Panc-1 (#CRL-1469) cells were obtained from American Type Culture Collection (ATCC; Manassas, VA, USA). HaCaT (# 300493) cells were obtained from Cytion (Heidelberg, Germany).

HEK293T and MCF-7 cells were cultured in DMEM/F-12 (Thermo Fisher Scientific), while A375, HaCaT, and Panc-1 cells were maintained in DMEM (Sigma-Aldrich). All media were supplemented with 10% fetal bovine serum (FBS). Cells were maintained at 37 °C in a humidified incubator. A375 cells were kept at 10% CO2, while all other cell lines (HEK293T, MCF-7, HaCaT, and Panc-1) were maintained at 5% CO2.

For the generation of stable HEK293T cell lines, cells were transfected at sub-confluency in T25 culture flasks using Roti®-fect (Carl Roth, Karlsruhe, Germany) with 4 µg of rEstus or rEstus2s in pCDNA3.1-Puro, or with rEstus-T2A-ANO1, rEstus-T2A-KCa3.1, rEstus2s-T2A-ANO1, rEstus2s-T2A-KCa3.1, K-GECO1-T2A-rEstus2s, K-GECO1-T2A-rEstus2s-T2A-ANO1, or K-GECO1-T2A-rEstus2s-T2A-KCa3.1 in pCDNA3.1-EF1α-Puro Cells were selected for two weeks in DMEM/F-12 supplemented with 10% FBS and 10 µg/ml puromycin (Gibco), with the medium refreshed every three days. Stable cell lines were subsequently maintained in medium without puromycin.

To generate stable cell lines, A375 and MCF-7 cells were transfected with the rEstus2s-pcDNA3.1(+)-Puro construct via electroporation and selected with 10 µM puromycin. Panc-1 and HaCaT cells were transduced using a lentiviral vector (rEstus2s-pCDH-EF1 α -Puro) and selected with 4 µg/ml and 3 µg/ml puromycin, respectively. The resulting cell lines were sorted by fluorescence-activated cell sorting (FACS). Cell sorting was performed on a BD FACSAria™ IIIu (BD Biosciences, Franklin Lakes, NJ, USA) equipped with four lasers and a 100 µm nozzle. Viable single cells exhibiting the highest fluorescence intensity in the GFP/FITC channel were isolated according to the gating strategy shown in Supplementary Data 3.

Lentiviral production and transduction

Lentiviral particles were produced by transient co-transfection of HEK293T cells. One day prior to transfection, 3.2 × 106 HEK293T cells were seeded into 60-mm culture dishes in high-glucose DMEM (Thermo Fisher Scientific) supplemented with 10% FBS and maintained at 37 °C with 5% CO2. At 80–90% confluency, cells were transfected with 6 µg of pCDH-EF1α-Puro-CMV-rEstus2s and the packaging plasmids pMDLg/PRRE (3 µg; Addgene #12251), pRSVrev (2.5 µg; Addgene #12253), and pMD2.G (1.5 µg; Addgene #12259) using 25 µl Lipofectamine 2000 (Thermo Fisher Scientific) in Opti-MEM.

The culture medium was replaced 16 h after transfection. Virus-containing supernatants were harvested at 24 h and 48 h, filtered through a 0.45-µm cellulose acetate filter (Carl Roth), and stored at −80 °C. For transduction, 1 × 105 Panc-1 or HaCaT cells were seeded per well of a 6-well plate and incubated with 600 µl of lentiviral supernatant. After 24 h, the medium was replaced, and stable transformants were selected using puromycin (4 µg/ml for Panc-1; 3 µg/ml for HaCaT). Selection efficiency was monitored using non-transduced control cells.

CRISPR-Cas9 knockout

For generating CRISPR-Cas9 knockout cell lines, we used the lentiCRISPRv2 system. The following guide RNAs (gRNAs) from the human CRISPR knockout pooled library A (GeCKOv2) were cloned into the lentiCRISPRv2 (Addgene #52961)77:

GJA1 (Cx43): 19135: TCAGCGCACCACTGGTCGCA, 19136: TGTGTTCTATGTGATGCGAA

GJC1 (Cx45): 19177: CATCTTCCCGAATCCGTCGT, 19179: GCAAGCCCTATGCAATGCGC

HEK293T cells were transiently transfected with the lentiCRISPRv2 expression plasmids using Roti®-fect. One day after transfection, cells were selected for 3 days with 10 μg/ml puromycin to eliminate non-transfected cells. Following selection, individual clones were isolated by serial dilution into 96-well plates. Individual clonal cell lines were grown to confluency and maintained in a T-25 culture flask. A successful knockout was confirmed by Western blot analysis. The Cx43 single knockout cell line was generated first using gRNAs 19135 and 19136. Based on the Cx43 knockout (Cx43 KO) line, a Cx43/Cx45 double knockout (Cx43/45 KO) line was subsequently generated using gRNAs 19177 and 19179.

Western Blot

Cells were washed once with ice-cold phosphate-buffered saline (PBS) and lysed in RIPA buffer (50 mM Tris pH 7, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 2 mM EGTA) supplemented with cOmplete protease inhibitor cocktail (Roche; distributed by Merck). Lysates were clarified by centrifugation (14,000 × g, 10 min, 4 °C), and samples were incubated at 70 °C for 10 min. Total protein (15 µg per lane) was resolved on 12% polyacrylamide gels alongside a size standard (PageRuler Prestained Protein Ladder, Thermo Fisher Scientific). Proteins were transferred to polyvinylidene difluoride (PVDF) membranes and blocked in Tris-buffered saline containing 0.1% Tween-20 (TBST) and 5% non-fat dry milk. Membranes were probed with mouse monoclonal antibodies from Santa Cruz Biotechnology: anti-Cx43 (sc-271837, 1:1000), anti-Cx45 (sc-374354, 1:1000), and anti-Vinculin (sc-73614, 1:2000). A peroxidase-conjugated goat anti-mouse secondary antibody (SeraCare, #5220-0341; 1:10000) was used for detection. Chemiluminescence was imaged using the Fusion FX Edge system with EvolutionCapt software (Vilber Lourmat).

qPCR

Total RNA was isolated from confluent cells using the RNeasy Mini Kit (Qiagen; cat. no. 74104). cDNA was generated using the First Strand cDNA Synthesis Kit (Thermo Fisher Scientific; #K1612). qPCR was performed on a Mastercycler ep realplex (Eppendorf) using Maxima SYBR Green qPCR Master Mix (Thermo Fisher Scientific; #K0251). Primers for GJC1 (Cx45; FH1/BH1-GJC1), GJA1 (Cx43; FH1/BH1-GJA1), and GJB3 (Cx31; FH1/BH1-GJB3) were obtained from Merck. Primers for ANO1 (QT00076013), KCNN4 (QT00003780), and β-actin (QT0095431) were obtained from Qiagen. All qPCR results were normalized to β-actin levels.

Combined electrophysiology and fluorescence imaging

For electrophysiological recordings, HEK293T cells were plated on 35-mm glass-bottom dishes (Ibidi, Martinsried, Germany) and transfected the following day with 1 µg of plasmid DNA per dish using Roti®-fect (Carl Roth, Karlsruhe, Germany). Electrophysiological and imaging experiments were performed one or two days after transfection.

Electrophysiological recordings were performed using an EPC10 double patch clamp amplifier controlled by PatchMaster software (HEKA Elektronik, Lambrecht, Germany) on an Axio Observer inverted microscope (Carl Zeiss, Jena, Germany). For fluorescence excitation, a Colibri-2 LED illumination system and an EC-Plan Neofluar 40× oil-immersion objective (NA 1.3, Zeiss) were used. Images were acquired with an ORCA-Flash 4.0 Digital Camera (C11440, Hamamatsu, Japan) controlled by SmartLux software (HEKA Elektronik).

For sensor development, mKate2 fusion constructs were used. mKate2 was excited with a 530-nm LED (Zeiss) that had an output of 1.8 mW. The filter set was as follows: excitation: BP 545/40 (Chroma), beam splitter: 565 LPXR (Chroma), emission: BP 608/65 (Delta Optical Thin Film). For excitation of GEVIs, a 470-nm LED (Zeiss) with an output of 0.7 mW was used. The filter set was as follows: excitation: BP 470/40 (Chroma), beam splitter: 495 LPXR (Chroma), emission: BP 525/50 (Delta Optical Thin Film). Images were acquired with a 90-ms camera exposure time at 5 Hz.

For limit of detection recordings (Fig. 1i, j), images were acquired with a 40 ms camera exposure time at 20 Hz. Excitation was achieved through simultaneous illumination with a 470-nm LED (Zeiss) with a BP 470/40 filter at 0.74 mW and a 400-nm LED (Zeiss) with a BP 400/10 filter (Thorlabs) at 0.12 mW. The filter cube contained a 495 LPXR beamsplitter and a BP 525/50 emission filter. The 400-nm LED was used to accelerate the sensor kinetics, as shown in Supplementary Fig. 4.

Sensor kinetics was evaluated using whole-cell patch clamp combined with photometry on an Axio Observer inverted microscope (Zeiss) equipped with an EC-Plan Neofluar 40× oil-immersion objective. Excitation light from a 470-nm LED (M470L1, Thorlabs) was passed through a modified filter set 38 (Zeiss), in which the excitation filter was replaced with a 492/SP filter (Semrock, Rochester, NY, USA). Emission light was detected using a photodiode (FDU photodiode with viewfinder, T.I.L.L. Photonics, Gräfelfing, Germany) and recorded at 20 kHz using PatchMaster software (HEKA Elektronik).

Patch clamp pipettes were made from borosilicate glass, coated with dental wax, and fire-polished to obtain resistances of 1–2 MΩ. For all electrophysiological recordings, the bath solution contained 146 mM NaCl, 4 mM KCl, 2 mM CaCl₂, 2 mM MgCl₂, and 10 mM HEPES, adjusted to pH 7.4 at 23 °C using NaOH. The pipette solution for sensor calibration contained 130 mM KCl, 2.5 mM MgCl₂, 10 mM EGTA, and 10 mM HEPES, adjusted to pH 7.4 at 23 °C using KOH. For recordings of KCa3.1 and ANO1 currents, the pipette solution contained 1 mM NaCl, 70 mM K+-gluconate, 50 mM KCl, 8 mM CaCl₂, 10 mM EGTA, 1.5 mM MgCl₂, and 20 mM HEPES, adjusted to pH 7.4 at 23 °C using KOH. The intracellular free Ca2+ concentration in this solution was calculated to be approximately 300 nM using WEBMAXC STANDARD.

Live-cell fluorescence imaging

For experiments with low cell densities, cells were seeded at a density of 20,000 cells per 35 mm glass-bottom dish (Ibidi) and imaged 48 h after plating. For confluent culture experiments, cells were seeded at either 80,000 cells per dish (imaged after 72 h) or 160,000 cells per dish (imaged after 48 h).

For live-cell imaging experiments (Figs. 2–6), stably transfected cells were washed once and subsequently maintained in the external bath solutions used in electrophysiological experiments, supplemented with 5 mM glucose. Cells were equilibrated in this solution for 15 min prior to image acquisition. Recordings were limited to a maximum duration of 15 min per sample. All recordings were performed at ambient temperature (23 °C).

Images were acquired at a frame rate of 5 Hz (Figs. 2 and 3) with alternating 90 ms exposures for excitation at either 400 nm (0.40 mW) and 470 nm (0.74 mW), or 470 nm (0.74 mW) and 530 nm (1.8 mW). Alternatively, images were acquired at 10 Hz (Figs. 3–5) using simultaneous illumination at 400 nm (0.12 mW) and 470 nm (0.74 mW). All experiments were performed using the same epifluorescence setup described for sensor calibration.

Cluster size analysis (Fig. 6) was performed on an inverted Eclipse Ti fluorescence microscope (Nikon, Tokyo, Japan) equipped with a 10× Plan Apo λ objective (NA 0.45, Nikon). Excitation was provided by an X-Cite 120 LED light source (Excelitas Technologies, Waltham, MA, USA) through a GFP-3035D-000 filter set (Semrock). Images were acquired at a frame rate of 4 Hz using a 14-bit DS-Qi2 CMOS camera (Nikon) controlled by NIS-Elements 4.6 software (Nikon).

Image data analysis

All raw image sets were analyzed using Fiji (ImageJ). For GEVI analysis, regions of interest (ROIs) were defined either along the cell periphery (Figs. 1–3) or over the entire cell area (Figs. 3–6). For FFCA and K-GECO1 experiments, ROIs were restricted to the cytosol to prevent signal contamination from the overlapping membranes of neighboring cells. All extracted data were background-corrected by subtracting the mean fluorescence of a cell-free region. Subsequent processing was performed in Igor Pro 9 (WaveMetrics). Initial transients, primarily attributed to photoswitching, were removed, and traces were corrected for photobleaching using a single-exponential decay function. For FFCA experiments and the experiments in Figs. 4 and 5, fluorescence traces were smoothed using a binning factor of 2.

To determine the relative molecular brightness during sensor development (Fig. 1), the green fluorescence intensity (Fgreen, GEVI) was normalized to the red fluorescence intensity (Fred, mKate2). The mean steady-state fluorescence ratio (R = Fgreen/Fred) was plotted as a function of membrane voltage (Vm) and fitted with a Boltzmann function (Eq. (1))

RVm=Rmax−ΔRmax1+e−Vm−Vhalfks 1

where Rmax is the maximum fluorescence ratio, ΔRmax is the maximal change in fluorescence ratio, Vhalf is the voltage at half-maximal response, and ks represents the slope factor. Fit parameters for all constructs are provided in Supplementary Table 1.

The voltage sensitivity (brightness change per voltage unit) was described by the first derivative of Eq. (1):

dR(Vm)dVm=−ΔRmaxeVm−Vhalfksks1+eVm−Vhalfks2 2

To calculate the fractional voltage sensitivity as a function of voltage, Eq. (2) was divided by Eq. (1).

For kinetic characterization of the GEVIs, the normalized fluorescence (F) response to voltage steps was analyzed using a double-exponential fit (Eq. (3)):

F(t)Ft=0=1−A(AfastA(1−e−tτfast)−AslowA(1−e−tτslow)) 3

where A represents the amplitude and τ the time constant of the fast and slow components, respectively.

To characterize fluorescence fluctuations, we calculated the relative fluctuation magnitude normalized to the mean fluorescence intensity of each trace. Key parameters extracted included the peak-to-peak amplitude, maximum positive and negative excursions from the mean, and the time variance. For co-expression experiments with rEstus2s and ion channels, channel opening events were defined as fluctuations exceeding a specific threshold relative to the mean: a > 10% increase for KCa3.1 or a > 15% decrease for ANO1.

The dependence of fluorescence volatility on cluster size (n, the number of cells in a cluster) was modeled by fitting a reciprocal decay function to the Fgreen time variance (σn2):

σn2=σi2n+offset 4

where σi2 represents the variance of an isolated cell and the offset accounts for the intrinsic background noise floor of the measurement system. This model assumes that for small Vm fluctuations, Fgreen is linearly proportional to Vm.

Statistics and reproducibility

Data are presented as means ± standard error of the mean (SEM), as indicated in the figure legends. For box plots, the central line indicates the median, the box limits indicate the 25th and 75th percentiles (interquartile range), and the whiskers extend to the 10th and 90th percentiles. For datasets with small sample sizes, individual data points are overlaid. The number of analyzed cells or traces (n) is provided in parentheses within the Figures. For comparisons between two independent groups, a two-sided Wilcoxon rank-sum test was performed. For multiple comparisons against a control group (Fig. 1h), a one-way ANOVA followed by Dunnett’s post-hoc test was used. Statistical significance is indicated as follows: * P < 0.05, ** P < 0.01, *** P < 0.001; n.s., not significant (P ≥ 0.05). For imaging experiments, data were compiled from 3–6 independent culture dishes. No data were excluded from the analysis. Key findings regarding Vm dynamics and bioelectric contact inhibition were robustly replicated across multiple independent cell lines as well as various experimental conditions. All attempts at replication were successful. Core biophysical principles were cross-validated using two different genetically encoded voltage indicators (rEstus and rEstus2s). Randomization was not applicable to this study, as experimental groups were defined by specific cell types, genetic modifications (e.g., CRISPR-Cas9 knockouts), or the expression of specific ion channels and sensors. Blinding was not performed during data acquisition, as the investigators required knowledge of the specific cell lines and constructs to perform targeted patch-clamp and imaging protocols.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Supplementary information

41467_2026_76758_MOESM2_ESM.pdf (121.3KB, pdf)

Description of Additional Supplementary Information

Supplementary Data 1 (23.1KB, zip)
Supplementary Data 2 (16.6KB, xlsx)
Supplementary Data 3 (60.2KB, pdf)
Supplementary Movie 1 (85.4MB, avi)
Supplementary Movie 2 (97.9MB, avi)
Reporting Summary (104.6KB, pdf)

Source data

Source Data (16.3MB, zip)

Acknowledgments

We thank Angela Roßner, Silke Tonndorf-Martini, and Sassrika N. C. W. Dehiwalage for technical support. We are grateful to Julia Drube for assistance with CRISPR-Cas9 experiments and to Ingrid Hilger for providing Panc-1 cells. We also thank Katrin Schubert and Michael Müller at the FACS core facility of the Fritz Lipmann Institute (FLI) for the sorting of stable cell lines.

Author contributions

Conceptualization: P.R. Methodology: P.R. and R.A.H. Investigation: P.R., R.A.H., A.G.N., R.S., R.M., S.R. and K.F. Formal Analysis: P.R. Visualization: P.R. Supervision: P.R. Writing—original draft: P.R. Writing—review & editing: P.R., R.A.H., A.G.N., R.S., S.H.H., R.M. and S.R. Funding Acquisition: S.H.H. and R.M.

Peer review

Peer review information

Nature Communications thanks Michael Levin, Salvador Mafe, and the other anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Funding

Simons Foundation Autism Research Initiative (SFARI) (SHH, RAH, 705944SH) German Academic Exchange Service (AGN, 91819480). Funding Program of the Free State of Thuringia to Promote Research, Technology, and Innovation (FTI) (RM, 2025 VFE 0064). Open Access funding enabled and organized by Projekt DEAL.

Data availability

All data are available in the main text or the supplementary materials. The source data and raw data traces underlying all figures are provided in a Source Data file. Sequence information is provided in Supplementary Data 1. The rEstus2s expression vector is available from Addgene (250991). Due to large file sizes, the raw imaging data are available on request from the corresponding author. There are no restrictions on access, and requests will be processed within 4 weeks. The previously reported GFP protein structure used in this work is available via PDB ID 2Y0G. Source data are provided with this paper.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

The online version contains supplementary material available at 10.1038/s41467-026-76758-z.

References

  • 1.Levin, M. Bioelectric signaling: reprogrammable circuits underlying embryogenesis, regeneration, and cancer. Cell184, 1971–1989 (2021). [DOI] [PubMed] [Google Scholar]
  • 2.Moreddu, R. Nanotechnology and cancer bioelectricity: bridging the gap between biology and translational medicine. Adv. Sci.11, 2304110 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Da Ros, A. et al. Leukemic cells hijack stromal bioelectricity to reprogram the bone marrow niche via CaV1.2-dependent mechanisms. Adv. Sci.12, e08940 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Venkataramani, V. et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell185, 2899–2917 (2022). [DOI] [PubMed] [Google Scholar]
  • 5.Prevarskaya, N., Skryma, R. & Shuba, Y. Ion channels in cancer: are cancer hallmarks oncochannelopathies? Physiol. Rev.98, 559–621 (2018). [DOI] [PubMed] [Google Scholar]
  • 6.Sasaki, M., Nakahara, M., Hashiguchi, T. & Ono, F. Membrane potential modulates ERK activity and cell proliferation in human cells. eLife13, RP101613 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zhou, Y. et al. Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling. Science349, 873–876 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pitt, G. S., Matsui, M. & Cao, C. Voltage-gated calcium channels in nonexcitable tissues. Annu. Rev. Physiol.83, 183–203 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.George, L. F. & Bates, E. A. Mechanisms underlying the influence of bioelectricity in development. Front. Cell Dev. Biol.10, 772230 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell144, 646–674 (2011). [DOI] [PubMed] [Google Scholar]
  • 11.Bell, D. C., Leanza, L., Gentile, S. & Sauter, D. R. News and views on ion channels in cancer: is cancer a channelopathy? Front. Pharmacol.14, 1258933 (2023). [Google Scholar]
  • 12.Pardo, L. A. & Stühmer, W. The roles of K+ channels in cancer. Nat. Rev. Cancer14, 39–48 (2013). [DOI] [PubMed] [Google Scholar]
  • 13.Britschgi, A. et al. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc. Natl. Acad. Sci. USA110, E1026–E1034 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Duvvuri, U. et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res.72, 3270–3281 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sauter, D. R. P., Novak, I., Pedersen, S. F., Larsen, E. H. & Hoffmann, E. K. ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). Pflug. Arch. Eur. J. Physiol.467, 1495–1508 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ruiz, C. et al. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. PLOS ONE7, e43265 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mo, X. et al. KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma. Acta Pharmacol. Sin.43, 735–746 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bulk, E. et al. Epigenetic dysregulation of KCa3.1 channels induces poor prognosis in lung cancer. Int. J. Cancer137, 1306–1317 (2015). [DOI] [PubMed] [Google Scholar]
  • 19.Bonito, B., Sauter, D. R. P., Schwab, A., Djamgoz, M. B. A. & Novak, I. KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34. Pflug. Arch. Eur. J. Physiol.468, 1865–1875 (2016). [DOI] [PubMed] [Google Scholar]
  • 20.Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol.28, 1248–1250 (2010). [DOI] [PubMed] [Google Scholar]
  • 21.Godse, N. R. et al. TMEM16A/ANO1 inhibits apoptosis via downregulation of Bim expression. Clin. Cancer Res.23, 7324–7332 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sui, Y. et al. Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells. PLoS ONE9, 115443 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Aasen, T. et al. Connexins in cancer: bridging the gap to the clinic. Oncogene38, 4429–4451 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Aasen, T., Mesnil, M., Naus, C. C., Lampe, P. D. & Laird, D. W. Gap junctions and cancer: communicating for 50 years. Nat. Rev. Cancer16, 775–788 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pun, R. et al. PKCμ promotes keratinocyte cell migration through Cx43 phosphorylation-mediated suppression of intercellular communication. iScience27, 109033 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lastwika, K. J., Dunn, C. A., Solan, J. L. & Lampe, P. D. Phosphorylation of connexin 43 at MAPK, PKC or CK1 sites each distinctly alters the kinetics of epidermal wound repair. J. Cell Sci.132, jcs234633 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Solan, J. L., Hingorani, S. R. & Lampe, P. D. Cx43 phosphorylation sites regulate pancreatic cancer metastasis. Oncogene40, 1909–1920 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Solan, J. L., Márquez-Rosado, L. & Lampe, P. D. Cx43 phosphorylation–mediated effects on ERK and Akt protect against ischemia reperfusion injury and alter the stability of the stress-inducible protein NDRG1. J. Biol. Chem.294, 11762–11771 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yang, Y. et al. Function of BKCa channels is reduced in human vascular smooth muscle cells from Han Chinese patients with hypertension. Hypertension61, 519–525 (2013). [DOI] [PubMed] [Google Scholar]
  • 30.Cone, C. D. & Tongier, M. Contact inhibition of division: involvement of the electrical transmembrane potential. J. Cell. Physiol.82, 373–386 (1973). [DOI] [PubMed] [Google Scholar]
  • 31.Rühl, P. et al. An ultrasensitive genetically encoded voltage indicator uncovers the electrical activity of non-excitable cells. Adv. Sci.11, 2307938 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Quicke, P. et al. Voltage imaging reveals the dynamic electrical signatures of human breast cancer cells. Commun. Biol.5, 1–14 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Yu, S. M. & Granick, S. Electric spiking activity in epithelial cells. Proc. Natl. Acad. Sci. USA122, e2427123122 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Melikov, R., Angelis, F. De & Moreddu, R. High-frequency extracellular spiking in electrically-active cancer cells. bioRxiv10.1101/2024.03.16.585162 (2024).
  • 35.Pereda, A. E. et al. Gap junction-mediated electrical transmission: regulatory mechanisms and plasticity. Biochim. biophys. Acta1828, 134 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sherman, A., Rinzel, J. & Keizer, J. Emergence of organized bursting in clusters of pancreatic beta-cells by channel sharing. Biophys. J.54, 411–425 (1988). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Villette, V. et al. Ultrafast two-photon imaging of a high-gain voltage indicator in awake behaving mice. Cell179, 1590–1608.e23 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Liu, Z. et al. Sustained deep-tissue voltage recording using a fast indicator evolved for two-photon microscopy. Cell185, 3408–3425.e29 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lu, X. et al. Widefield imaging of rapid pan-cortical voltage dynamics with an indicator evolved for one-photon microscopy. Nat. Commun.14, 1–22 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Evans, S. W. et al. A positively tuned voltage indicator for extended electrical recordings in the brain. Nat. Methods20, 1104–1113 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Platisa, J. et al. High-speed low-light in vivo two-photon voltage imaging of large neuronal populations. Nat. Methods20, 1095–1103 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hao, Y. A. et al. A fast and responsive voltage indicator with enhanced sensitivity for unitary synaptic events. Neuron112, 3680–3696.e8 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bernert, A., Rühl, P., Schönherr, R. & Heinemann, S. H. Crosstalk of KCNH1 and KCNH5 gain-of-function mutations leading to epilepsy and neurodevelopmental disorders. Mol. Brain19, 16 (2026). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Sen, T. et al. Influence of the first chromophore-forming residue on photobleaching and oxidative photoconversion of EGFP and EYFP. Int. J. Mol. Sci.20, 5229 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Rühl, P. et al. Monitoring of compound resting membrane potentials of cell cultures with ratiometric genetically encoded voltage indicators. Commun. Biol.4, 1–11 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Shcherbo, D. et al. Far-red fluorescent tags for protein imaging in living tissues. Biochem. J.418, 567–574 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Nagai, T. et al. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol.20, 87–90 (2002). [DOI] [PubMed] [Google Scholar]
  • 48.Nair, A. G. et al. Absolute membrane potential recording with ASAP-type genetically encoded voltage indicators using fluorescence lifetime imaging. ACS Chem. Neurosci.16, 4636–4646 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Xu, F., Shi, D. Q., Lau, P. M., Lin, M. Z. & Bi, G. Q. Excitation wavelength optimization improves photostability of ASAP-family GEVIs. Mol. Brain11, 32 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Cervera, J., Manzanares, J. A., Levin, M. & Mafe, S. Oscillatory phenomena in electrophysiological networks: the coupling between cell bioelectricity and transcription. Comput. Biol. Med.180, 108964 (2024). [DOI] [PubMed] [Google Scholar]
  • 51.De, S. & Djamgoz, M. B. A. Membrane Potential Bistability in Human Breast Cancer MDA-MB-231 Cells: a “Hodgkin–Huxley Type” Model. Bioelectricity (2025).
  • 52.Barghouth, P. G., Thiruvalluvan, M. & Oviedo, N. J. Bioelectrical regulation of cell cycle and the planarian model system. Biochim. Biophys. Acta1848, 2629–2637 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lazzari-Dean, J. R., Gest, A. M. M. & Miller, E. W. Optical estimation of absolute membrane potential using fluorescence lifetime imaging. eLife8, e44522 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lazzari-Dean, J. R. & Miller, E. W. Optical estimation of absolute membrane potential using one- and two-photon fluorescence lifetime imaging microscopy. Bioelectricity3, 197–203 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Gest, A. M. M., Grenier, V. & Miller, E. W. Optical estimation of membrane potential values using fluorescence lifetime imaging microscopy and hybrid chemical-genetic voltage indicators. Bioelectricity6, 34–41 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Gest, A. M. M. et al. A red-emitting carborhodamine for monitoring and measuring membrane potential. Proc. Natl. Acad. Sci. USA121, e2315264121 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.McMillen, P. & Levin, M. Lifetime imaging reveals long-distance non-neural bioelectric patterns on timescales from seconds to hours. Dev. Biol.10.1016/j.ydbio.2026.08.001 (2026) [DOI] [PubMed]
  • 58.McNamara, H. M. et al. Bioelectrical domain walls in homogeneous tissues. Nat. Phys. 2020 16:316, 357–364 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kulkarni, R. U. et al. A rationally designed, general strategy for membrane orientation of photoinduced electron transfer-based voltage-sensitive dyes. ACS Chem. Biol.12, 407–413 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Bonzanni, M. et al. Defined extracellular ionic solutions to study and manipulate the cellular resting membrane potential. Biol. Open9, bio048553 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Yang, M. & Brackenbury, W. J. Membrane potential and cancer progression. Front. Physiol.4, 185 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Stein, R. B., Gossen, E. R. & Jones, K. E. Neuronal variability: noise or part of the signal? Nat. Rev. Neurosci.6, 389–397 (2005). [DOI] [PubMed] [Google Scholar]
  • 63.White, J. A., Rubinstein, J. T. & Kay, A. R. Channel noise in neurons. Trends Neurosci.23, 131–137 (2000). [DOI] [PubMed] [Google Scholar]
  • 64.Adams, D. S. & Levin, M. Endogenous voltage gradients as mediators of cell-cell communication: strategies for investigating bioelectrical signals during pattern formation. Cell tissue Res.352, 95–122 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Nielsen, M. S. et al. Gap Junctions. Compr. Physiol.2, 1981–2035 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Malan, D., Rühl, P., Heinemann, S. H., Fleischmann, B. K. & Geisen, C. Generation and characterization of a human induced pluripotent stem cell line (hiPSC) expressing the rEstus voltage sensor under doxycycline induction. Stem Cell Res.93, 103972 (2026). [DOI] [PubMed] [Google Scholar]
  • 67.Stramer, B. & Mayor, R. Mechanisms and in vivo functions of contact inhibition of locomotion. Nat. Rev. Mol. Cell Biol.18, 43–55 (2016). [DOI] [PubMed] [Google Scholar]
  • 68.Pavel, M. et al. Contact inhibition controls cell survival and proliferation via the YAP/TAZ-autophagy axis. Nat. Commun.9, 1–18 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Vanni, G. et al. Microtubule architecture connects AMOT stability to YAP/TAZ mechanotransduction and Hippo signalling. Nat. Cell Biol.27, 1725–1738 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Cervera, J., Levin, M. & Mafe, S. Bioelectricity of non-excitable cells and multicellular pattern memories: biophysical modeling. Phys. Rep.1004, 1–31 (2023). [Google Scholar]
  • 71.Goglia, A. G. et al. A live-cell screen for altered Erk dynamics reveals principles of proliferative control. Cell Syst.10, 240–253.e6 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Purvis, J. E. & Lahav, G. Encoding and decoding cellular information through signaling dynamics. Cell152, 945–956 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Aoki, K. et al. Stochastic ERK activation induced by noise and cell-to-cell propagation regulates cell density-dependent proliferation. Mol. Cell52, 529–540 (2013). [DOI] [PubMed] [Google Scholar]
  • 74.Cervera, J., Levin, M. & Mafe, S. Top-down perspectives on cell membrane potential and protein transcription. Sci. Rep16, 1996 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Cervera, J., Manzanares, J. A. & Mafe, S. Electrical coupling in ensembles of nonexcitable cells: modeling the spatial map of single cell potentials. J. Phys. Chem. B119, 2968–2978 (2015). [DOI] [PubMed] [Google Scholar]
  • 76.Shen, Y. et al. A genetically encoded Ca2+ indicator based on circularly permutated sea anemone red fluorescent protein eqFP578. BMC Biol.16, 1–16 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods11, 783–784 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Royant, A. & Noirclerc-Savoye, M. Stabilizing role of glutamic acid 222 in the structure of Enhanced Green Fluorescent Protein. J. Struct. Biol.174, 385–390 (2011). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

41467_2026_76758_MOESM2_ESM.pdf (121.3KB, pdf)

Description of Additional Supplementary Information

Supplementary Data 1 (23.1KB, zip)
Supplementary Data 2 (16.6KB, xlsx)
Supplementary Data 3 (60.2KB, pdf)
Supplementary Movie 1 (85.4MB, avi)
Supplementary Movie 2 (97.9MB, avi)
Reporting Summary (104.6KB, pdf)
Source Data (16.3MB, zip)

Data Availability Statement

All data are available in the main text or the supplementary materials. The source data and raw data traces underlying all figures are provided in a Source Data file. Sequence information is provided in Supplementary Data 1. The rEstus2s expression vector is available from Addgene (250991). Due to large file sizes, the raw imaging data are available on request from the corresponding author. There are no restrictions on access, and requests will be processed within 4 weeks. The previously reported GFP protein structure used in this work is available via PDB ID 2Y0G. Source data are provided with this paper.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES